RACHEL LESSOR: Open Payments
NPI 1275054538 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,573 in 84 payments from 18 companies in 2025. Trend: 2023 $829 · 2024 $1,509 · 2025 $1,573
Food & beverage: $1,573
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $299 |
| ABBVIE INC. | 17 | $211 |
| AstraZeneca Pharmaceuticals LP | 8 | $178 |
| ViiV Healthcare Company | 6 | $153 |
| Lilly USA, LLC | 9 | $136 |
| Otsuka America Pharmaceutical, Inc. | 6 | $116 |
| Astellas Pharma US Inc | 4 | $64 |
| Lundbeck LLC | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Amgen Inc. | 3 | $53 |
Products named: FANAPT, REXULTI, VRAYLAR, MOUNJARO, HETLIOZ, APRETUDE, AIRSUPRA, Veozah.
Industry payments across MO — which companies pay providers there.
